GlassScriptPhysician profile
Mark M Medeiros
NPI 1679570832
$1,745.74
in general payments reported to CMS, 2019-2025
19 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $70.07 · 2022: $195 · 2023: $334 · 2024: $318 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $498.17 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boston Scientific Corporation | $281.16 | 2022-2023 | Watchman Access System |
| Novo Nordisk INC | $187.43 | 2019-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $137.37 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $109.41 | 2019-2024 | Eliquis |
| Lilly USA, LLC | $104.00 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.16 | 2019-2025 | Jardiance |
| Medtronic, INC. | $63.48 | 2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Amgen INC. | $50.69 | 2019-2024 | Repatha |
| Cleerly, INC. | $50.48 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Lundbeck LLC | $38.39 | 2024 | Rexulti |
| Seqirus USA INC | $34.44 | 2019-2020 | |
| Abbott Laboratories | $20.15 | 2025 | Proclaim |
| Sanofi Pasteur INC. | $18.16 | 2020 | |
| Abbvie INC. | $16.75 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $14.15 | 2025 | Senza |
| Exact Sciences Corporation | $13.57 | 2025 | Cologuard Collection Kit |
| Allergan, INC. | $13.47 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Medeiros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.